Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.60 |
| ▸ | MGAM | O43451 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MYC | P01106 | 1/20 | 0.46 |
| ▸ | MAX | P61244 | 1/20 | 0.46 |
| ▸ | IGFBP3 | P17936 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | DHODH | Q02127 | 2/20 | 0.45 |
| ▸ | IGFBP5 | P24593 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Transtorine SCHEMBL17596601 | 1.00 | ALOX15 (0.60) | ALOX15MGAMALDH1A1HPGDHSD17B10 | |
| Transtorine SCHEMBL1421892 | 0.98 | ALOX15 (0.58) | ALOX15MGAMALDH1A1HPGDHSD17B10 | |
| Transtorine SCHEMBL480985 | 0.98 | ALOX15 (0.58) | ALOX15MGAMALDH1A1HPGDHSD17B10 | |
| Transtorine SCHEMBL21384236 | 0.86 | ALOX15 (0.48) | ALOX15MGAMALDH1A1HPGDHSD17B10 | |
| SCHEMBL247555 | 0.85 | GRM2 (0.59) | ALDH1A1 | |
| SCHEMBL17718271 | 0.85 | ALDH1A1 (0.49) | ALOX15MGAMALDH1A1HPGDHSD17B10 | |
| Transtorine SCHEMBL10895515 | 0.84 | G6PD (0.59) | ALOX15ALDH1A1HPGDTHRBPDE10A | |
| Transtorine SCHEMBL7937597 | 0.84 | ALDH1A1 (0.44) | ALOX15MGAMALDH1A1HPGDHSD17B10 | |
| Hydrochloric Acid SCHEMBL17769122 | 0.84 | GRM2 (0.57) | ALDH1A1 | |
| SCHEMBL11827386 | 0.82 | IGFBP5 (0.47) | ALOX15MGAMALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6045 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146967-A1 | DEVICE AND SENSOR FOR DETECTION OF AN ANALYTE | REMINDED, INC. (US) | 2026-05-28 | — | — | US | claimed |
| US-20260108550-A1 | NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF A RED BLOOD CELL DISORDER | NUVAMID SA (CH) | 2026-04-23 | — | — | US | claimed |
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4405047-B1 | CANNABINOID FORMULATION FOR ORAL ADMINISTRATION | CB21 PHARMA S R O (CZ) | 2026-04-01 | — | — | EP | claimed |
| EP-4072319-B1 | COMPOSITIONS FOR USE IN THE REDUCTION OF NOCICEPTION AND OTHER HEALTH BENEFITS IN INFANTS AND YOUNG CHILDREN | NESTLE SA (CH) | 2026-04-01 | — | — | EP | claimed |
| US-20260076956-A1 | METHODS FOR REGRESSING OR REVERSING FIBROSIS AND/OR LIVER CIRRHOSIS IN A SUBJECT IN NEED THEREOF USING HIGH-DOSE NIACIN, OR A NIACIN ANALOG THEREOF | US GOV VETERANS AFFAIRS (US) | 2026-03-19 | — | — | US | claimed |
| US-12551459-B2 | Combination of kynurenine and antigen presenting cells (APC) as therapeutics and methods for their use in immune modulation | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2026-02-17 | — | — | US | claimed |
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-01-08 | — | — | US | claimed |
| US-20250367192-A1 | BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME | NEUREN PHARMACEUTICALS LTD (NZ) | 2025-12-04 | — | — | US | claimed |
| EP-4648788-A1 | LIPID BINDING PROTEIN MOLECULE THERAPY | Abionyx Pharma SA (FR) | 2025-11-19 | — | — | EP | claimed |
| WO-1995003815-A1 | ANTIBODIES SPECIFIC TO QUINOLINIC ACID | GEORGETOWN UNIVERSITY (US) | 1995-02-09 | — | — | WO | claimed |
| EP-0564676-A1 | Light polarizing material based on quinaldic acid derivatives | RESEARCH FRONTIERS INCORPORATED (US) | 1993-10-13 | — | — | EP | claimed |
| EP-0321516-B1 | 3-INDOLEPYRUVIC ACID DERIVATIVES AND PHARMACEUTICAL USE THEREOF | POLIFARMA S.p.A. (IT) | 1993-03-03 | — | — | EP | claimed |
| US-5039528-A | EAA antagonists as anti-emetic drugs | OLNEY JOHN W (US) | 1991-08-13 | — | — | US | claimed |
| EP-0432994-A2 | Excitatory amino acid antagonists as anti-emetic drugs | Olney, John William (US) | 1991-06-19 | — | — | EP | claimed |
| EP-0421946-A2 | 3-indolepyruvic acid derivatives their method of production and therapeutic use | POLIFARMA S.p.A. (IT) | 1991-04-10 | — | — | EP | claimed |
| WO-1988007851-A1 | LIPOSOME ENTRAPPED N-METHYL-D-ASPARTATE RECEPTOR BLOCKERS | INNOVATIVE THERAPEUTICS CORPORATION (US) | 1988-10-20 | — | — | WO | claimed |
| US-4620850-A | HYDROXYBENZOLFURANONE | WELLA AKTIENGESELLSCHAFT (DE) | 1986-11-04 | — | — | US | claimed |
| EP-0026474-B1 | COMPOSITION AND PROCESS FOR OXIDATIVE DYEING OF HAIR | Wella Aktiengesellschaft (DE) | 1983-06-08 | — | — | EP | claimed |
| EP-0026473-B1 | OXIDATIVE HAIR-DYEING COMPOSITION | Wella Aktiengesellschaft (DE) | 1983-05-25 | — | — | EP | claimed |